Preskoči na vsebino
CureSight Naprava Za Zdravljenje Lenih Oči – avtor Kobi Kor

Delo CureSight Naprava Za Zdravljenje Lenih Oči avtorja Kobi Kor je izjemno cenjeni dobitnik prestižne nagrade 2022 Železna nagrada A' Design Award v tekmovalni kategoriji Oblikovanje medicinskih naprav in medicinske opreme.


ŽeleznaMedicinski izdelek· 2022

CureSight Naprava Za Zdravljenje Lenih Oči

avtor/ica: Kobi Kor

Naročnik: Novasight

Dobitnik nagrade Železna nagrada A' Design Award v kategoriji Medicinski izdelek

22,237

Potrjeni dobitnik nagrade

Preverite status nagrade za #133911

Barve

Dizajn

O dizajnu CureSight Naprava Za Zdravljenje Lenih Oči

Proces oblikovanja CureSight je bil osredotočen na ustvarjanje izdelka in rešitve zdravljenja, ki bo imela pozitiven družbeni učinek in pomagala pacientom, med katerimi je večina otrok, da se izognejo nelagodju in zadregi, ki sta povezana s tradicionalnim zdravljenjem z očesnim obližem. Zasnova prav tako poudarja, da sta videz in občutek izdelka bistvenega pomena pri motiviranju in opolnomočenju otrok. Navdih za stilsko zasnovo je prišel iz tehnoloških pripomočkov, ki jih otroci radi uporabljajo in se z njimi igrajo. Zasnova oblike zagotavlja gladek in sodoben videz izdelka medicinskega pripomočka.

Priznanje

O nagradi Železna nagrada A' Design Award

CureSight Naprava Za Zdravljenje Lenih Oči je prejemnik Železne nagrade A' Design Award, prestižnega priznanja, ki se podeljuje dobrim oblikovanjem, ki izpolnjujejo profesionalne in industrijske zahteve, pričakovane od dobro zasnovanih stvaritev. Prejemniki Železne nagrade kažejo veliko spretnost, visoko specializacijo, strokovno razumevanje in ustvarjalne zmožnosti svojih ustvarjalcev. Od CureSight Naprava Za Zdravljenje Lenih Oči se pričakuje, da bo visoko cenjena, občudovana in ljubljena stvaritev, ki je praktična in inovativna. To oblikovanje, nagrajeno z Železno nagrado A' Design Award, vključuje najboljše prakse panoge in ima kompetentne tehnične lastnosti, povezane s strokovnim znanjem in talentom. Zaradi svoje temeljitosti si CureSight Naprava Za Zdravljenje Lenih Oči zasluži spoštovanje in je zasnovan tako, da zagotavlja izboljšave kakovosti življenja, ki pomagajo narediti svet boljši kraj.

V ozadju dizajna

Komplet za medije

Zasluge, člani ekipe in tehnične podrobnosti, ki jih je posredoval oblikovalec.

Edinstvene lastnosti
The curesight is a powerful solution with great potential to totally change the treatment of lazy eye condition, with the important advantage of treating the lazy eye from the comfort of home and by watching any tv or streaming video content.
This healthcare solution for lazy eye condition integrates high-end technologies for eye-tracking and ai software tools for smart analyzing of the lazy eye condition and providing personal custom treatment. The gold standard care for lazy eye is placing a patch over the strong eye, an old-fashioned solution that suffers from very low compliance.
Dimenzije in embalaža
product net dimensions
Height 230mm
Width 390mm
Depth 60mm
Oznake
amlyopia, lazy eye, medical device, product design, social impact, degital healthcare
Proizvodna tehnologija
The design activity started with a brainstorming meeting to learn more about the problem from the clinical and user needs aspects, and to outline the main big limitations of today's treatment methods.
We also discussed the ergonomics and usability needs to be able to provide the best treatment.
during the design process, we tested several design concepts both aesthetically and with physical mockups,
Production technologies include aluminum CNC machining and anodize plating, for the front bezel and plastic injection for the back cover and small covers.
Oblikovalski izziv
The creative challenge was to dress the unique technology components with style and to provide a good user experience to the users, the specific usability needs to enable good treatment for various populations and make it an appealing and empowering treatment device, and lead to important social impact
Raziskave
Following an intense effort over the last 18 months, the company officially announced that the company successfully met the primary endpoint of the CureSight randomized, controlled pivotal trial of amblyopia treatment against the gold standard patching.
This is the first-ever pivotal study in which a digital device was shown to be non-inferior to eye patching for amblyopia treatment in children.
The study also exhibited 93% adherence to the curesight treatment, as well as a 93% likelihood of the parents choosing curesight over patching.
Inspiracija
The inspiration for the curesight product started from a personal experience when one of my kids needed to treat the lazy eye condition with the eye patch solution, I learned from this experience about the discomfort of wearing the eye patch for a few hours every day and especially how embarrassing it is from the social point of view.
The inspiration for the styling design came from the tech gadgets that kids love to use and play with, to provide a slick and modern design to a medical device product type, the front aluminum bezel, and the back swallowtail gives the product a clean gadget look.
Trajanje projekta
The project started in 2019 in Tel Aviv, and finished in late 2021, the project was exhibited at the CES in January 2020 in Las Vegas
Potek delovanja
The patient, most likely kids will have the fun be treated by the Curesight while watching any video content they love to watch without any degradation in quality and from the comfort of home.
Člani ekipe
Kobi Kor
Tal Samet
Zasluge za slike
All images
Photograph and Illustrations: Novasight and Kobi Kor

Sponzorirano

Raziščite onkraj Designers.org

Odkrijte izdelke, storitve in priložnosti naših oglaševalskih partnerjev.

Dober dizajn si zasluži odlično prepoznavnost

A' Design Award je mednarodno strokovno priznanje za dober dizajn. Sodelujte na tekmovanju A' Design Award in si pridobite priložnost za zasluženo priznanje, sloves, ugled in odmevnost svojega dela. Prijavite svoje delo na A' Design Award in se potegujte za prestižno nagrado A' Design Prize.

Prijavite se